Disclosures
Scott S. Zamvil, MD, PhD, FAAN
| Scientific Advisory Boards | |
| Dr. Zamvil has received honoraria for serving on Data Safety Monitoring Boards for MS trials conducted by Opexa, BioMS, Teva Pharmaceuticals, Inc. and Eli Lilly and Co. Foundation. | |
| Funding for travel or speaker honoraria | |
| (1) Biogen - Speaker honoraria and advisory board meetings (2) Teva - Speaker honoraria and advisory board meetings (3) Alexion - Speaker honoraria and advisory board meetings (4) Novartis - Speaker honoraria and advisory board meetings | |
| Editorial Boards | |
| (1) Neurology, Neuroimmunology and Neuroinflammation, Deputy Editor, 2014-present | |
| Patents | |
| "Aquaporin-4 peptides and methods for using same" (SF2010-074; USF-461PRV (pending). The application describes the discovery of aquaporin-4 T cell determinants in neuromyelitis optica patients and the use for antigen-specific tolerance. | |
| Consultancies | |
| SSZ has served as a consultant to Biogen Idec, Teva Neuroscience, EMD-Serono, Genzyme, Novartis and Roche. | |
| Speakers' Bureaus | |
| Advanced Health Media, 2009-present Biogen, 2009-present Alexion, 2019-present Viela Bio, 2020 | |
| Research Support, Commercial Entities | |
| (1) Biogen - speaker and advisory board meetings (2) Teva - speaker and advisory board meetings (3) Genentech - advisory board meeting (4) Novartis - advisory board meetings (5) Genzyme - advisory board meetings (6) Alexion - advisory board meeting | |
| Research Support, Government Entities | |
| NIH RO1 AI131624-O1A1 NIH R21 NS10815990-01 | |
| Research Support, Academic Entities | |
| NMSS RG 1701-26628 NMSS RG 1801-29861 | |
| Research Support, Foundations and Societies | |
| Alexander M. and June L. Maisin Foundation, PI | |